A citation-based method for searching scientific literature

Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
Times Cited: 1082



N W Kim, M A Piatyszek, K R Prowse, C B Harley, M D West, P L Ho, G M Coviello, W E Wright, S L Weinrich, J W Shay. Science 1994
Times Cited: 5768




List of shared articles



Times cited

Integrated analysis of telomerase enzymatic activity unravels an association with cancer stemness and proliferation.
Nighat Noureen, Shaofang Wu, Yingli Lv, Juechen Yang, W K Alfred Yung, Jonathan Gelfond, Xiaojing Wang, Dimpy Koul, Andrew Ludlow, Siyuan Zheng. Nat Commun 2021
1

The role of telomerase and viruses interaction in cancer development, and telomerase-dependent therapeutic approaches.
Ali Salimi-Jeda, Fariba Badrzadeh, Maryam Esghaei, Asghar Abdoli. Cancer Treat Res Commun 2021
0

The Regulation of ROS- and BECN1-Mediated Autophagy by Human Telomerase Reverse Transcriptase in Glioblastoma.
Xuelu Ding, Ziyang Nie, Zhaoyuan She, Xue Bai, Qiuhui Yang, Feng Wang, Fei Wang, Xin Geng. Oxid Med Cell Longev 2021
0

Telomerase Regulation: A Role for Epigenetics.
Fatma Dogan, Nicholas R Forsyth. Cancers (Basel) 2021
0

Alternative splicing is a developmental switch for hTERT expression.
Alex Penev, Andrew Bazley, Michael Shen, Jef D Boeke, Sharon A Savage, Agnel Sfeir. Mol Cell 2021
1

Cancer-associated POT1 mutations lead to telomere elongation without induction of a DNA damage response.
Won-Tae Kim, Kelsey Hennick, Joshua Johnson, Brendan Finnerty, Seunga Choo, Sarah B Short, Casey Drubin, Ryan Forster, Mary L McMaster, Dirk Hockemeyer. EMBO J 2021
0

High frequency of PIK3CA and TERT promoter mutations in fibromatosis-like spindle cell carcinomas.
Siyuan Zhong, Shuling Zhou, Anqi Li, Hong Lv, Ming Li, Shaoxian Tang, Xiaoli Xu, Ruohong Shui, Wentao Yang. J Clin Pathol 2021
0

Human telomerase is directly regulated by non-telomeric TRF2-G-quadruplex interaction.
Shalu Sharma, Ananda Kishore Mukherjee, Shuvra Shekhar Roy, Sulochana Bagri, Silje Lier, Meenakshi Verma, Antara Sengupta, Manish Kumar, Gaute Nesse, Deo Prakash Pandey,[...]. Cell Rep 2021
0

Human TERT promoter mutations as a prognostic biomarker in glioma.
Branka Powter, Sarah A Jeffreys, Heena Sareen, Adam Cooper, Daniel Brungs, Joseph Po, Tara Roberts, Eng-Siew Koh, Kieran F Scott, Mila Sajinovic,[...]. J Cancer Res Clin Oncol 2021
0

Shelterin complex gene: Prognosis and therapeutic vulnerability in cancer.
Vikas Kumar Bhari, Durgesh Kumar, Surendra Kumar, Rajeev Mishra. Biochem Biophys Rep 2021
0

Cancer-specific loss of TERT activation sensitizes glioblastoma to DNA damage.
Alexandra M Amen, Christof Fellmann, Katarzyna M Soczek, Shawn M Ren, Rachel J Lew, Gavin J Knott, Jesslyn E Park, Andrew M McKinney, Andrew Mancini, Jennifer A Doudna,[...]. Proc Natl Acad Sci U S A 2021
0

TERT Promoter Alterations in Glioblastoma: A Systematic Review.
Nathalie Olympios, Vianney Gilard, Florent Marguet, Florian Clatot, Frédéric Di Fiore, Maxime Fontanilles. Cancers (Basel) 2021
0

Therapeutic targeting of FOS in mutant TERT cancers through removing TERT suppression of apoptosis via regulating survivin and TRAIL-R2.
Rengyun Liu, Jie Tan, Xiaopei Shen, Ke Jiang, Chaoqun Wang, Guangwu Zhu, Mingzhao Xing. Proc Natl Acad Sci U S A 2021
0

Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAFV600E-driven human cancers.
Yongxing Wu, Liang Shi, Yuelei Zhao, Pu Chen, Rongrong Cui, Meiju Ji, Nongyue He, Maode Wang, Gang Li, Peng Hou. NPJ Precis Oncol 2021
1

The Jekyll and Hyde of Cellular Senescence in Cancer.
Dilara Demirci, Bengisu Dayanc, Fatma Aybuke Mazi, Serif Senturk. Cells 2021
2

The hTERT core promoter forms three parallel G-quadruplexes.
Robert C Monsen, Lynn DeLeeuw, William L Dean, Robert D Gray, T Michael Sabo, Srinivas Chakravarthy, Jonathan B Chaires, John O Trent. Nucleic Acids Res 2020
10

Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens.
Yong Luo, Chaolong Lin, Yidi Zou, Fei Ju, Wenfeng Ren, Yanhua Lin, Yale Wang, Xiaoxuan Huang, Huiling Liu, Zeng Yu,[...]. Oncoimmunology 2020
1